Towards unveiling the genetics of neurodegenerative diseases

Seminars in Neurology

Volumn 31, Issue 5, 2011, Pages 531-541

  Lill, Christina M ^a,b   Bertram, Lars ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ALSGene; AlzGene; Alzheimer's disease; amyotrophic lateral sclerosis; frontotemporal dementia; genetics; genome wide association study; GWAS; meta analysis; mutation; Neurodegeneration; neurodegenerative disease; Parkinson's disease; PDGene; polymorphism

Indexed keywords

ABC TRANSPORTER; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANGIOGENIN; APOLIPOPROTEIN E; CD33 ANTIGEN; CLUSTERIN; COMPLEMENT; COPPER ZINC SUPEROXIDE DISMUTASE; DJ 1 PROTEIN; DNA; GAMMA SECRETASE; LEUCINE RICH REPEAT KINASE 2; MEMBRANE PROTEIN; NEUROTRANSMITTER; NUCLEIC ACID BINDING PROTEIN; PHOSPHATIDYLINOSITOL; PHOSPHOTRANSFERASE; PRESENILIN 1; PRESENILIN 2; RIBOSOME RNA; RNA; RNA BINDING PROTEIN; TAU PROTEIN; UBIQUITIN PROTEIN LIGASE E3; VALOSIN CONTAINING PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME 9; DEGENERATIVE DISEASE; DNA BINDING; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RNA BINDING;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; FRONTOTEMPORAL DEMENTIA; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 84856200093     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1299791     Document Type: Article

References (45)

1. Bertram L, Tanzi R E. The genetic epidemiology of neurodegenerative disease. J Clin Invest 2005 115 6 1449-1457 (Pubitemid 40814649)
2. Soto C, Estrada L D. Protein misfolding and neurodegeneration. Arch Neurol 2008 65 2 184-189 (Pubitemid 351240778)
3. Siontis KCM, Patsopoulos N A., Ioannidis JPA. Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur J Hum Genet 2010 18 7 832-837
4. Cooper G M., Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 2011 12 9 628-640
5. Lupski J R., Reid J G., Gonzaga-Jauregui C et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010 362 13 1181-1191
6. Johnson J O., Mandrioli J, Benatar M et al, ITALSGEN Consortium. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010 68 5 857-864
7. Vilario-Gell C, Wider C, Ross O A. et al. VPS35 mutations in Parkinson disease. Am J Hum Genet 2011 89 1 162-167
8. Cruts M, Van Broeckhoven C. Molecular genetics of Alzheimer's disease. Ann Med 1998 30 6 560-565 (Pubitemid 29012304)
9. Tanzi R E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005 120 4 545-555 (Pubitemid 40269768)
10. Gatz M, Reynolds C A., Fratiglioni L et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006 63 2 168-174 (Pubitemid 43213878)
11. Farrer L A., Cupples L A., Haines J L. et al, APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 1997 278 16 1349-1356 (Pubitemid 27449696)
12. Bertram L. Alzheimer's genetics in the GWAS era: a continuing story of replications and refutations; Curr Neurol Neurosci Rep 2011 11 3 246-253
13. Bertram L, McQueen M B., Mullin K, Blacker D, Tanzi R E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007 39 1 17-23 (Pubitemid 46026496)
14. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 2010 31 7 763-780
15. Chartier-Harlin M C., Dachsel J C., Vilario-Gell C et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 2011 89 3 398-406
16. Zimprich A, Benet-Pags A, Struhal W et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 2011 89 1 168-175
17. Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 2009 11 e22
18. Ramirez A, Heimbach A, Grndemann J et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006 38 10 1184-1191 (Pubitemid 44470365)
19. Paisán-Ruiz C, Guevara R, Federoff M et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 2010 25 12 1791-1800
20. Nalls M A., Plagnol V, Hernandez D G. et al, International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011 377 9766 641-649
21. Do C B., Tung J Y., Dorfman E et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011 7 6 e1002141
22. International Parkinson's Disease Genomics Consortium (IPDGC) Wellcome Trust Case Control Consortium 2 (WTCCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011 7 6 e1002142
23. Lill C M., Roehr J T., McQueen M B. et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. (Under review).
24. Stefansson H, Helgason A, Thorleifsson G et al. A common inversion under selection in Europeans. Nat Genet 2005 37 2 129-137
25. Ezquerra M, Pastor P, Gaig C et al. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy. Neurobiol Aging 2011 32 3 547 e11-e16
26. Satake W, Nakabayashi Y, Mizuta I et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009 41 12 1303-1307
27. Sidransky E, Nalls M A., Aasly J O. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009 361 17 1651-1661
28. Mackenzie I R., Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010 9 10 995-1007
29. Ingelsson M, Hyman B T. Disordered proteins in dementia. Ann Med 2002 34 4 259-271
30. Neumann M, Sampathu D M., Kwong L K. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006 314 5796 130-133 (Pubitemid 44547757)
31. Dejesus-Hernandez M, Mackenzie I R., Boeve B F. et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 2011 72 2 245-256
32. Renton A E., Majounie E, Waite A et al, TheITALSGEN Consortium. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 2011 72 2 257-268
33. Van Deerlin V M., Sleiman PMA, Martinez-Lage M et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 2010 42 3 234-239
34. Shatunov A, Mok K, Newhouse S et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 2010 9 10 986-994
35. Laaksovirta H, Peuralinna T, Schymick J C. et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 2010 9 10 978-985
36. Cruts M, Gijselinck I, van der Zee J et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006 442 7105 920-924 (Pubitemid 44285947)
37. Schröder R, Watts GDJ, Mehta S G. et al. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 2005 57 3 457-461 (Pubitemid 40343972)
38. Mackenzie IRA, Neumann M, Bigio E H. et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010 119 1 1-4
39. Lill C M., Abel O, Bertram L, Al-Chalabi A. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotroph Lateral Scler 2011 12 4 238-249
40. Kabashi E, Valdmanis P N., Dion P et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008 40 5 572-574 (Pubitemid 351601218)
41. Lagier-Tourenne C, Polymenidou M, Cleveland D W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010 19 R1 R46-R64
42. Deng H X., Chen W, Hong S T. et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011 477 7363 211-215
43. van Es M A., Veldink J H., Saris CGJ et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 2009 41 10 1083-1087
44. Elden A C., Kim H-J, Hart M P. et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010 466 7310 1069-1075
45. Ross O A., Rutherford N J., Baker M et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 2011 20 16 3207-3212